drugset / Trial / NCT01097304
Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia
NaSingle-groupOpen-labelPrevention
Summary
This pilot phase II trial studies how well ursodiol works in treating patients with Barrett esophagus or cells that look abnormal under a microscope but are not cancer (low-grade dysplasia). Chemoprevention is the use of certain drugs to keep cancer from forming. The use of ursodiol may keep cancer for forming in patients with Barrett esophagus or low-grade dysplasia.
Timeline
- Start
- 2010-04
- Primary completion
- 2014-04
- Completion
- 2014-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ursodeoxycholic Acid | Small molecule | — | Oral |